The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Oxidative Stress‐Related Mechanisms in Schizophrenia Pathogenesis and New Treatment Perspectives
Open accessAbstract
Schizophrenia is recognized to be a highly heterogeneous disease at various levels, from genetics to clinical manifestations and treatment sensitivity. This heterogeneity is also reflected in the variety of oxidative stress‐related mechanisms contributing to the phenotypic realization and manifestation of schizophrenia. At the molecular level, these mechanisms are supposed to include genetic causes that increase the susceptibility of individuals to oxidative stress and lead to gene expression dysregulation caused by abnormal regulation of redox‐sensitive transcriptional factors, noncoding RNAs, and epigenetic mechanisms favored by environmental insults. These changes form the basis of the prooxidant state and lead to altered redox signaling related to glutathione deficiency and impaired expression and function of redox‐sensitive transcriptional factors (Nrf2, NF‐κ B, FoxO, etc.). At the cellular level, these changes lead to mitochondrial dysfunction and metabolic abnormalities that contribute to aberrant neuronal development, abnormal myelination, neurotransmitter anomalies, and dysfunction of parvalbumin‐positive interneurons. Immune dysfunction also contributes to redox imbalance. At the whole‐organism level, all these mechanisms ultimately contribute to the manifestation and development of schizophrenia. In this review, we consider oxidative stress‐related mechanisms and new treatment perspectives associated with the correction of redox imbalance in schizophrenia. We suggest that not only antioxidants but also redox‐regulated transcription factor‐targeting drugs (including Nrf2 and FoxO activators or NF‐κ B inhibitors) have great promise in schizophrenia. But it is necessary to develop the stratification criteria of schizophrenia patients based on oxidative stress‐related markers for the administration of redox‐correcting treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biological insights from 108 schizophrenia-associated genetic loci
Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) · Nature · doi:10.1038/nature13595 · Cited by 7,577 · cited 12×
“Indeed, SNPs of PDCD11 gene, coding the NF-κB-binding protein (NFBP) or the protein RRP5 homolog, have shown a statistically significant association with schizophrenia according to the GWAS results [91].”
BackgroundResultInfluentialROS function in redox signaling and oxidative stress
Schieber, M., & Chandel, N. S. (2014) · Current Biology · doi:10.1016/j.cub.2014.03.034 · Cited by 6,931 · cited 3×
“Accurate redox regulation is necessary for cellular signaling because reactive oxygen and nitrogen species (ROS and RNS) participate in numerous signaling pathways [127, 128].”
BackgroundCommon polygenic variation contributes to risk of schizophrenia and bipolar disorder
The International Schizophrenia Consortium (2009) · Nature · doi:10.1038/nature08185 · Cited by 4,821
Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling
Ray, P. D., Huang, B.-W., & Tsuji, Y. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.01.008 · Cited by 4,373 · cited 4×
“Accurate redox regulation is necessary for cellular signaling because reactive oxygen and nitrogen species (ROS and RNS) participate in numerous signaling pathways [127, 128].”
BackgroundInfluentialFerroptosis: past, present and future
Li, J., Cao, F., Yin, H.-L., Huang, Z.-J., Lin, Z.-T., Mao, N., Sun, B., & Wang, G. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2298-2 · Cited by 4,171
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
An Energy Budget for Signaling in the Grey Matter of the Brain
Attwell, D., & Laughlin, S. B. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200110000-00001 · Cited by 3,543 · cited 1×
“There is evidence indicating an equally high need for cellular metabolism of inhibiting GABAergic interneurons [291].”
BackgroundStress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase
Brunet, A., Sweeney, L. B., Sturgill, J. F., Chua, K. F., Greer, P. L., Lin, Y., Tran, H., Ross, S. E., Mostoslavsky, R., Cohen, H. Y., et al. (2004) · Science · doi:10.1126/science.1094637 · Cited by 3,239
Analysis of shared heritability in common disorders of the brain
The Brainstorm Consortium, Anttila, V., Bulik-Sullivan, B., Finucane, H. K., Walters, R. K., Bras, J., Duncan, L., Escott-Price, V., Falcone, G. J., Gormley, P., et al. (2018) · Science · doi:10.1126/science.aap8757 · Cited by 1,924 · cited 2×
“Besides, many discovered associations can also be related to other mental diseases [92], which is indicative of some general mechanisms of the development of mental disorders.”
BackgroundSynaptic Energy Use and Supply
Harris, J. J., Jolivet, R., & Attwell, D. (2012) · Neuron · doi:10.1016/j.neuron.2012.08.019 · Cited by 1,747
Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity
Fünfschilling, U., Supplie, L. M., Mahad, D., Boretius, S., Saab, A. S., Edgar, J., Brinkmann, B. G., Kassmann, C. M., Tzvetanova, I. D., Möbius, W., et al. (2012) · Nature · doi:10.1038/nature11007 · Cited by 1,523 · cited 1×
“During CNS maturation, the resistance of OLs to oxidative damage increases due to the elevated glutathione levels [238], the transition from the oxidative to the glycolytic mechanism [239], the rise of the longevity of myelin proteins [240], and metabolic support of axons by myelin sheathes [241].”
BackgroundGenome-wide association analysis identifies 13 new risk loci for schizophrenia
Multicenter Genetic Studies of Schizophrenia Consortium, Ripke, S., Psychosis Endophenotypes International Consortium, Wellcome Trust Case Control Consortium 2, O'Dushlaine, C., Chambert, K., Moran, J. L., Kähler, A. K., Akterin, S., Bergen, S. E., et al. (2013) · Nature Genetics · doi:10.1038/ng.2742 · Cited by 1,496
White matter in learning, cognition, and psychiatric disorders
Fields, R. D. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.04.001 · Cited by 1,337 · cited 1×
“Myelination of the human brain proceeds actively in the postnatal period, but the myelin content in the brain peaks at middle age, which coincides in time with the massive remodeling of synaptic contacts in the cerebral cortex [216].”
BackgroundTranscriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder
Gandal, M. J., Zhang, P., Hadjimichael, E., Walker, R. L., Chen, C., Liu, S., Won, H., van Bakel, H., Varghese, M., Wang, Y., et al. (2018) · Science · doi:10.1126/science.aat8127 · Cited by 1,247
Homayoun, H., & Moghaddam, B. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2213-07.2007 · Cited by 1,231
13 reasons why the brain is susceptible to oxidative stress
Cobley, J. N., Fiorello, M. L., & Bailey, D. M. (2018) · Redox Biology · doi:10.1016/j.redox.2018.01.008 · Cited by 1,215 · cited 1×
“Metals with mixed valence (especially iron and copper) can contribute to the development of OS in neurons [12].”
BackgroundShared molecular neuropathology across major psychiatric disorders parallels polygenic overlap
Gandal, M. J., Haney, J. R., Parikshak, N. N., Leppa, V., Ramaswami, G., Hartl, C., Schork, A. J., Appadurai, V., Buil, A., Werge, T. M., et al. (2018) · Science · doi:10.1126/science.aad6469 · Cited by 1,095 · cited 1×
“The downregulation of coexpressed genemodules associated withmitochondria in a larger sample of schizophrenia patients was also shown [209].”
BackgroundCortical parvalbumin interneurons and cognitive dysfunction in schizophrenia
Lewis, D. A., Curley, A. A., Glausier, J. R., & Volk, D. W. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.10.004 · Cited by 1,071 · cited 1×
“Numerous studies, including postmortem, genetic, and in vivo electrophysiological experiments in murine models of schizophrenia, consider the disruption of parvalbumin(PV-) positive GABAergic interneurons as a critical pathophysiological mechanism of schizophrenia [322].”
BackgroundLingappan, K. (2018) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2017.11.002 · Cited by 1,051
Lisman, J. E., Coyle, J. T., Green, R. W., Javitt, D. C., Benes, F. M., Heckers, S., & Grace, A. A. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.02.005 · Cited by 1,010 · cited 1×
“And the modern view of the pathogenesis of schizophrenia is based on the hypofunction of the NMDA receptor and the loss of GABAergic neurons [308].”
BackgroundSynaptic AMPA receptor plasticity and behavior
Kessels, H. W., & Malinow, R. (2009) · Neuron · doi:10.1016/j.neuron.2009.01.015 · Cited by 993
Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment
Khandaker, G. M., Cousins, L., Deakin, J., Lennox, B. R., Yolken, R., & Jones, P. B. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)00122-9 · Cited by 926 · cited 1×
“Inflammation and increased oxidative stress could constitute a common pathway between early genetic and environmental factors (such as prenatal infections, obstetric complications, hypoxia, or stress during pregnancy) and psychosis [246, 247].”
BackgroundAmminger, G. P., Schäfer, M. R., Papageorgiou, K., Klier, C. M., Cotton, S. M., Harrigan, S. M., Mackinnon, A., McGorry, P. D., & Berger, G. E. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.192 · Cited by 896
Mirnics, K., Middleton, F. A., Marquez, A., Lewis, D. A., & Levitt, P. (2000) · Neuron · doi:10.1016/s0896-6273(00)00085-4 · Cited by 882
Hambright, W. S., Fonseca, R. S., Chen, L., Na, R., & Ran, Q. (2017) · Redox Biology · doi:10.1016/j.redox.2017.01.021 · Cited by 851
Integrative functional genomic analysis of human brain development and neuropsychiatric risks
Li, M., Santpere, G., Imamura Kawasawa, Y., Evgrafov, O. V., Gulden, F. O., Pochareddy, S., Sunkin, S. M., Li, Z., Shin, Y., Zhu, Y., et al. (2018) · Science · doi:10.1126/science.aat7615 · Cited by 810
Takeuchi, H., Jin, S., Wang, J., Zhang, G., Kawanokuchi, J., Kuno, R., Sonobe, Y., Mizuno, T., & Suzumura, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600504200 · Cited by 749
Redox regulation of FoxO transcription factors
Klotz, L.-O., Sánchez-Ramos, C., Prieto-Arroyo, I., Urbánek, P., Steinbrenner, H., & Monsalve, M. (2015) · Redox Biology · doi:10.1016/j.redox.2015.06.019 · Cited by 747 · cited 14×
“The forkhead box class O (FoxO) family of transcription factors are critical regulators of the expression of genes involved in cellular oxidative stress response, ROS detoxification, DNA repair, energy homeostasis, and glucose metabolism (reviewed in [143]).”
BackgroundInfluentialTLR signaling tailors innate immune responses in human microglia and astrocytes
Jack, C. S., Arbour, N., Manusow, J., Montgrain, V., Blain, M., McCrea, E., Shapiro, A., & Antel, J. P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4320 · Cited by 734 · cited 1×
“Microglia express most TLRs, and their expression levels are altered by microglial activation [252].”
BackgroundInteractions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease
Zucca, F. A., Segura-Aguilar, J., Ferrari, E., Muñoz, P., Paris, I., Sulzer, D., Sarna, T., Casella, L., & Zecca, L. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.012 · Cited by 659
Boksa, P. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.03.005 · Cited by 603
The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders
Réus, G. Z., Fries, G. R., Stertz, L., Badawy, M., Passos, I. C., Barichello, T., Kapczinski, F., & Quevedo, J. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.05.018 · Cited by 594
Ketamine-Induced Loss of Phenotype of Fast-Spiking Interneurons Is Mediated by NADPH-Oxidase
Behrens, M. M., Ali, S. S., Dao, D. N., Lucero, J., Shekhtman, G., Quick, K. L., & Dugan, L. L. (2007) · Science · doi:10.1126/science.1148045 · Cited by 585
Qin, L., Liu, Y., Wang, T., Wei, S.-J., Block, M. L., Wilson, B., Liu, B., & Hong, J.-S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307657200 · Cited by 574 · cited 1×
“LPS stimulation of NOX2 activity in microglia may occur through binding with complement receptor 3 (CR3, MAC1, also called CD11b/CD18) [258].”
BackgroundBerk, M., Copolov, D., Dean, O., Lu, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., Judd, F., Katz, F., Katz, P., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.03.004 · Cited by 552
Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo
Do, K. Q., Trabesinger, A. H., Kirsten‐Krüger, M., Lauer, C. J., Dydak, U., Hell, D., Holsboer, F., Boesiger, P., & Cuénod, M. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00229.x · Cited by 540 · cited 1×
“Numerous data are indicative of the decreased concentration of reduced glutathione and increased concentration of oxidized glutathione in plasma [47, 48], erythrocytes [49], cerebrospinal fluid [50], and different brain regions [50–52] in first-episode, nonmedicated, medicated, and chronic schizophrenia patients.”
BackgroundImmune mediators in the brain and peripheral tissues in autism spectrum disorder
Estes, M. L., & McAllister, A. K. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3978 · Cited by 514 · cited 1×
“In addition to the disruption of BBB and placental barrier permeability, cytokines in the brain regulate the expression of major histocompatibility complex I (MHC I), coordinating synaptic pruning [168, 169].”
BackgroundPerineuronal nets protect fast-spiking interneurons against oxidative stress
Cabungcal, J.-H., Steullet, P., Morishita, H., Kraftsik, R., Cuenod, M., Hensch, T. K., & Do, K. Q. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300454110 · Cited by 512
Control of cortical GABA circuitry development by Nrg1 and ErbB4 signalling
Fazzari, P., Paternain, A. V., Valiente, M., Pla, R., Luján, R., Lloyd, K., Lerma, J., Marín, O., & Rico, B. (2010) · Nature · doi:10.1038/nature08928 · Cited by 501
Synaptic vesicle release regulates myelin sheath number of individual oligodendrocytes in vivo
Mensch, S., Baraban, M., Almeida, R., Czopka, T., Ausborn, J., El Manira, A., & Lyons, D. A. (2015) · Nature Neuroscience · doi:10.1038/nn.3991 · Cited by 398
Glutathione Precursor, N-Acetyl-Cysteine, Improves Mismatch Negativity in Schizophrenia Patients
Lavoie, S., Murray, M. M., Deppen, P., Knyazeva, M. G., Berk, M., Boulat, O., Bovet, P., Bush, A. I., Conus, P., Copolov, D., et al. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301624 · Cited by 371
Merritt, K., Egerton, A., Kempton, M. J., Taylor, M. J., & McGuire, P. K. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.0442 · Cited by 367 · cited 1×
“Symptoms of schizophrenia are associated with elevations in glutamatergic metabolites across several brain regions [367] and oxidative stress [40].”
BackgroundHärtig, W., Derouiche, A., Welt, K., Brauer, K., Grosche, J., Mäder, M., Reichenbach, A., & Brückner, G. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01784-9 · Cited by 339
Peet, M., Brind, J., Ramchand, C. N., Shah, S., & Vankar, G. K. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00083-9 · Cited by 329 · cited 1×
“…Rating Scale Fenton et al., 2001 [405] No significant change in PANSS, Abnormal Involuntary Movement Syndrome scale, Clinical Global Impression scale Peet et al., 2001 [401]; Peet et al., 2002 [402] Significant reduction in PANSS total Amminger et al. 2010 [403] Significantly reduced positive,…”
BackgroundAltered glutathione redox state in schizophrenia.
Yao, J. K., Leonard, S., & Reddy, R. (2006) · Disease Markers · doi:10.1155/2006/248387 · Cited by 321
Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis
Hardingham, G. E., & Do, K. Q. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.19 · Cited by 304
Antioxidants, Redox Signaling, and Pathophysiology in Schizophrenia: An Integrative View
Yao, J. K., & Keshavan, M. S. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3603 · Cited by 285
Steullet, P., Cabungcal, J. H., Monin, A., Dwir, D., O'Donnell, P., Cuenod, M., & Do, K. Q. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2014.06.021 · Cited by 262
Early maternal separation: a rodent model of depression and a prevailing human condition
Vetulani, J. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71505-6 · Cited by 255
Oskvig, D. B., Elkahloun, A. G., Johnson, K. R., Phillips, T. M., & Herkenham, M. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.01.015 · Cited by 248 · cited 1×
“confirm that lipopolysaccharide- (LPS-) induced maternal immune activation leads to an increase of expression profiles of oxidative stress-related genes and a decrease of expression profiles of critical neurodevelopmental genes in the fetal brain [114].”
BackgroundAntioxidant and bioenergetic coupling between neurons and astrocytes
Fernandez-Fernandez, S., Almeida, A., & Bolaños, J. P. (2012) · Biochemical Journal · doi:10.1042/bj20111943 · Cited by 247
Schizophrenia and Oxidative Stress: Glutamate Cysteine Ligase Modifier as a Susceptibility Gene
Tosic, M., Ott, J., Barral, S., Bovet, P., Deppen, P., Gheorghita, F., Matthey, M.-L., Parnas, J., Preisig, M., Saraga, M., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/507566 · Cited by 234
Synapse elimination and learning rules co-regulated by MHC class I H2-Db
Lee, H., Brott, B. K., Kirkby, L. A., Adelson, J. D., Cheng, S., Feller, M. B., Datwani, A., & Shatz, C. J. (2014) · Nature · doi:10.1038/nature13154 · Cited by 228
Parvalbumin interneurons mediate neuronal circuitry-neurogenesis coupling in the adult hippocampus
Song, J., Sun, J., Moss, J., Wen, Z., Sun, G. J., Hsu, D., Zhong, C., Davoudi, H., Christian, K. M., Toni, N., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3572 · Cited by 223 · cited 1×
“Recent studies have shown that suppressed PV interneuron activity decreases the survival and maturation of hippocampal neurons in newborns [326].”
BackgroundInvolvement of NOX2 in the Development of Behavioral and Pathologic Alterations in Isolated Rats
Schiavone, S., Sorce, S., Dubois-Dauphin, M., Jaquet, V., Colaianna, M., Zotti, M., Cuomo, V., Trabace, L., & Krause, K.-H. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.04.033 · Cited by 208 · cited 1×
“A treatment NOX inhibitor apocynin prevented histopathological and behavioral alterations [123].”
MethodEvidence-based umbrella review of 162 peripheral biomarkers for major mental disorders
Carvalho, A. F., Solmi, M., Sanches, M., Machado, M. O., Stubbs, B., Ajnakina, O., Sherman, C., Sun, Y. R., Liu, C. S., Brunoni, A. R., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0835-5 · Cited by 204
Bordt, E. A., & Polster, B. M. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.07.033 · Cited by 202 · cited 2×
“Additionally, the release of cytokines or gliotransmitters by activated astroglia and microglia controls BBB permeability in brain pathologies associated with excessive angiogenesis, cerebrovascular remodeling, and blood-brain barrier-mediated neuroinflammation also observed in schizophrenia [253].”
BackgroundRedox-sensitive cysteines bridge p300/CBP-mediated acetylation and FoxO4 activity
Dansen, T. B., Smits, L. M. M., van Triest, M. H., de Keizer, P. L. J., van Leenen, D., Koerkamp, M. G., Szypowska, A., Meppelink, A., Brenkman, A. B., Yodoi, J., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.194 · Cited by 201 · cited 2×
“Moreover, the effects are different depending on protein kinases; for instance, phosphorylation by Akt usually inactivates FoxO1a, FoxO3a, FoxO4, and FoxO6 proteins, whereas JNK activates FoxO4 and inactivates FoxO3a [143].”
BackgroundMHCI negatively regulates synapse density during the establishment of cortical connections
Glynn, M. W., Elmer, B. M., Garay, P. A., Liu, X.-B., Needleman, L. A., El-Sabeawy, F., & McAllister, A. K. (2011) · Nature Neuroscience · doi:10.1038/nn.2764 · Cited by 198 · cited 1×
“In addition to the disruption of BBB and placental barrier permeability, cytokines in the brain regulate the expression of major histocompatibility complex I (MHC I), coordinating synaptic pruning [168, 169].”
BackgroundAstrocyte NMDA receptors' activity sustains neuronal survival through a Cdk5–Nrf2 pathway
Jimenez-Blasco, D., Santofimia-Castaño, P., Gonzalez, A., Almeida, A., & Bolaños, J. P. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2015.49 · Cited by 196 · cited 25×
“In schizophrenia patients under conditions of systemic oxidative stress, the decreased Nrf2 expression in peripheral blood lymphocytes was discovered [139].”
BackgroundInfluentialHaslund‐Vinding, J., McBean, G., Jaquet, V, & Vilhardt, F. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13425 · Cited by 169 · cited 3×
“Initial molecular signaling pathways underlying microglial activation includes activation of toll-like receptors (TLRs), cytokine receptors, complement receptor 3, CD36 receptors, ionotropic and metabotropic purinergic receptors, and neurotransmitter receptors [248].”
BackgroundInfluentialSmigielski, L., Jagannath, V., Rössler, W., Walitza, S., & Grünblatt, E. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0601-3 · Cited by 168 · cited 3×
“Epigenetic mechanisms can serve a connecting link between environmental and genetic factors (reviewed in [112, 124, 125]).”
BackgroundSIRT1 Mediates Depression-Like Behaviors in the Nucleus Accumbens
Kim, H.-D., Hesterman, J., Call, T., Magazu, S., Keeley, E., Armenta, K., Kronman, H., Neve, R. L., Nestler, E. J., & Ferguson, D. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0212-16.2016 · Cited by 158 · cited 3×
“SIRT1 is associated with the depression behavior in the mouse model [152] and with depressive symptoms in schizophrenia patients [153].”
BackgroundMüller, M., Felmy, F., Schwaller, B., & Schneggenburger, R. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5582-06.2007 · Cited by 155 · cited 1×
“Parvalbumin is a Ca-binding protein that has little effect on excitatory potentials but significantly increases the decay rate of the signal [324].”
BackgroundDakhale, G. N., Khanzode, S. D., Khanzode, S. S., & Saoji, A. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0117-1 · Cited by 131
Holland, F. H., Ganguly, P., Potter, D. N., Chartoff, E. H., & Brenhouse, H. C. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.02.023 · Cited by 125
Kulak, A., Steullet, P., Cabungcal, J.-H., Werge, T., Ingason, A., Cuenod, M., & Do, K. Q. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4858 · Cited by 124 · cited 1×
“Nevertheless, there is a decrease of canonical antioxidant systems, including peroxidases, oxidoreductases, oxidases, and dismutases, confirmed by multiple studies in schizophrenia [281, 282].”
BackgroundReceptors, Ion Channels, and Signaling Mechanisms Underlying Microglial Dynamics
Madry, C., & Attwell, D. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.637157 · Cited by 109 · cited 1×
“Ionotropic P2X and metabotropic P2Y purinergic receptors are important for the regulation of the microglial actin cytoskeleton [262].”
BackgroundAdapting brain metabolism to myelination and long‐range signal transduction
Hirrlinger, J., & Nave, K. (2014) · Glia · doi:10.1002/glia.22737 · Cited by 109
Neuroendocrine profile in a rat model of psychosocial stress: Relation to oxidative stress
Colaianna, M., Schiavone, S., Zotti, M., Tucci, P., Morgese, M. G., Bäckdahl, L., Holmdahl, R., Krause, K.-H., Cuomo, V., & Trabace, L. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4569 · Cited by 107
Sivrioglu, E. Y., Kirli, S., Sipahioglu, D., Gursoy, B., & Sarandöl, E. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.07.004 · Cited by 102
Cabungcal, J.-H., Nicolas, D., Kraftsik, R., Cuénod, M., Do, K. Q., & Hornung, J.-P. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.01.003 · Cited by 96
Reddy, I. A., Pino, J. A., Weikop, P., Osses, N., Sørensen, G., Bering, T., Valle, C., Bluett, R. J., Erreger, K., Wortwein, G., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.86 · Cited by 96
Rodríguez-Santiago, B., Brunet, A., Sobrino, B., Serra-Juhé, C., Flores, R., Armengol, L., Vilella, E., Gabau, E., Guitart, M., Guillamat, R., et al. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.53 · Cited by 88
Zhong, Y., Dong, G., Luo, H., Cao, J., Wang, C., Wu, J., Feng, Y.-Q., & Yue, J. (2012) · Toxicology · doi:10.1016/j.tox.2012.08.009 · Cited by 77 · cited 1×
“At the chronic effect of ethanol, the amount of ROS and NO in the brain increases through induction of NADPH oxidase and NO synthase under the exposure to glial cytochrome P450-2E1 (CYP2E1) [175, 176].”
BackgroundBeneficial effects of N-acetylcysteine in treatment resistant schizophrenia
Bulut, M., Savas, H. A., Altindag, A., Virit, O., & Dalkilic, A. (2009) · The World Journal of Biological Psychiatry · doi:10.1080/15622970903144004 · Cited by 73 · cited 1×
“As stated above, clinical trial results indicate that additional antioxidant therapy has beneficial effects, including for treatment-resistant schizophrenia patients [421].”
ResultMistry, M., Gillis, J., & Pavlidis, P. (2013) · BMC Neuroscience · doi:10.1186/1471-2202-14-105 · Cited by 59
Wang, X., Pinto-Duarte, A., Sejnowski, T. J., & Behrens, M. M. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4907 · Cited by 46
Genetic liability to schizophrenia is associated with exposure to traumatic events in childhood
Sallis, H. M., Croft, J., Havdahl, A., Jones, H. J., Dunn, E. C., Davey Smith, G., Zammit, S., & Munafò, M. R. (2021) · Psychological Medicine · doi:10.1017/s0033291720000537 · Cited by 38
Cited by
Mayilswami, S., Raval, N. P., Tomar, R., Sharma, S., Praveena, S. M., Kataria, N., Selvasembian, R., Shanmugam, S. R., Nath, R., Malakar, A., et al. (2025) · Environmental Science: Advances · doi:10.1039/d4va00405a · Cited by 11
Unveiling the gut microbiota blueprint of schizophrenia: a multilevel omics approach
Qi, D., Liu, P., Wang, Y., Tai, X., & Ma, S. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1452604 · Cited by 8
Trends in Sudden Death Among Schizophrenia Inpatients
Popa, A.-V., Ifteni, P. I., Petric, P. S., Țâbian, D., & Teodorescu, A. (2025) · Medicina · doi:10.3390/medicina61122081
Metadata
- Authors
- Ermakov, E. A., Dmitrieva, E. M., Parshukova, D. A., Kazantseva, D. V., Vasilieva, A. R., & Smirnova, L. P.
- Venue
- Oxidative Medicine and Cellular Longevity
- Publisher
- Wiley
- Published
- 2021-01
- Volume
- 2021
- Issue
- 1
- Pages
- 8881770-8881770
- ISSN
- 1942-0994 (ISSN-L)
- 1942-0900
- OpenAlex
- W3122208075
- Cited by
- 233
- References
- 80
- FWCI
- 25.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.